News
The S&P 500 eked out a gain of 0.1% on Monday, May 19, 2025, as investors weighed the implications of Moody's downgrading its ...
Shares of Humana Inc. rallied 3.94% to $247.34 Monday, on what proved to be an all-around positive trading session for the ...
Shares of Humana Inc. rallied 4.61% to $237.96 Friday, on what proved to be an all-around favorable trading session for the ...
Humana has a P/E ratio of 16.4 based on its 12 month trailing earnings per share of $14.17. Considering its future earnings ...
Other health insurers in the S&P 500, including Humana, Molina Healthcare and Cigna, saw their stock prices decline. Companies in the broader healthcare space, including Elevance Health, Centene and ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
But a unique database of investment returns that dates back to 1875 shows that high tariffs can coexist with stock-market gains. Steven Goldstein is based in London and responsible for MarketWatch ...
Revenue Growth: Over the 3M period, Humana showcased positive performance, achieving a revenue ... Analysts typically rate each stock once per quarter. Some analysts will also offer forecasts ...
Financial giants have made a conspicuous bullish move on Humana ... present market position and performance In the last month, 5 experts released ratings on this stock with an average target ...
Despite these developments, Humana's stock performance remained flat over the past week. During the same period, broader markets saw gains, bolstered by strong earnings from major tech companies.
In premarket trading, Humana’s stock rose 6.03%, reflecting investor confidence in the company’s robust performance and strategic outlook. According to InvestingPro analysis, Humana currently appears ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results